Gene: UPP1 (uridine phosphorylase 1) Homo sapiens
Analyze
Symbol:
UPP1
Name:
uridine phosphorylase 1
Description:
Predicted to have uridine phosphorylase activity. Predicted to be involved in pyrimidine nucleoside catabolic process and pyrimidine nucleoside salvage. Localizes to the nucleoplasm.
Type:
protein-coding
RefSeq Status:
REVIEWED
Also known as:
UDRPASE; UP; UPASE; UPase 1; UPP; urdPase 1
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Upp1 (uridine phosphorylase 1) HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Upp1 (uridine phosphorylase 1) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Upp1 (uridine phosphorylase 1) NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
UPP1 (uridine phosphorylase 1) NCBI
Ortholog
Canis lupus familiaris (dog):
LOC100856638 (uridine phosphorylase 1-like) HGNC
EggNOG, Ensembl, HomoloGene, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Upp1 (uridine phosphorylase 1) NCBI
Ortholog
Sus scrofa (pig):
UPP1 (uridine phosphorylase 1) HGNC
EggNOG, Ensembl, NCBI, OMA, OrthoDB, Panther, Treefam
Other homologs 2
Canis lupus familiaris (dog):
UPP1 (uridine phosphorylase 1) HGNC
HomoloGene, NCBI
Rattus norvegicus (Norway rat):
Upp2 (uridine phosphorylase 2) HGNC
EggNOG, OrthoDB
Mus musculus (house mouse):
Upp2 (uridine phosphorylase 2) HGNC
OrthoDB
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Danio rerio (zebrafish):
upp1 (uridine phosphorylase 1)
Alliance
DIOPT (Ensembl Compara, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam, ZFIN)
Drosophila melanogaster (fruit fly):
CG17224
Alliance
DIOPT (Ensembl Compara, Hieranoid, OrthoFinder, PANTHER, PhylomeDB, TreeFam)
Caenorhabditis elegans (roundworm):
upp-1
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup)
Drosophila melanogaster (fruit fly):
CG3788
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Drosophila melanogaster (fruit fly):
CG6330
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 7 48,088,308 - 48,108,746 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh37 7 48,128,355 - 48,148,330 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 7 48,094,880 - 48,114,855 (+) NCBI NCBI36 hg18 NCBI36 Celera 7 48,227,538 - 48,247,515 (+) NCBI Cytogenetic Map 7 p12.3 NCBI HuRef 7 48,013,948 - 48,033,924 (+) NCBI HuRef CHM1_1 7 48,131,900 - 48,152,030 (+) NCBI CHM1_1 CRA_TCAGchr7v2 7 48,168,224 - 48,188,201 (+) NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Annotations - ClinVar
long QT syndrome IAGP RGD:10395426 8554872 ClinVar Annotator: match by term: Long QT syndrome ClinVar PMID:26132555 pleomorphic xanthoastrocytoma IAGP RGD:12859021 8554872 ClinVar Annotator: match by term: Pleomorphic xanthoastrocytoma ClinVar PMID:28299358
Imported Annotations - CTD
allergic contact dermatitis EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:16033404 respiratory allergy EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:24211530
(S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of UPP1 mRNA CTD PMID:23825647 17alpha-ethynylestradiol increases expression ISO RGD:1313670 6480464 Ethinyl Estradiol results in increased expression of UPP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1305566 6480464 Ethinyl Estradiol results in increased expression of UPP1 mRNA CTD PMID:17557909 17alpha-ethynylestradiol multiple interactions ISO RGD:1313670 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of UPP1 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA CTD PMID:20660070 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA CTD PMID:16704738 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313670 6480464 Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313670 6480464 Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313670 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA CTD PMID:17942748 2,4-diaminotoluene increases expression ISO RGD:1313670 6480464 2, 4-diaminotoluene results in increased expression of UPP1 mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression ISO RGD:1305566 6480464 2, 4-dinitrotoluene affects the expression of UPP1 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of UPP1 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1313670 6480464 tetrabromobisphenol A results in increased expression of UPP1 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:1313670 6480464 Methylcholanthrene results in increased expression of UPP1 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1313670 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1313670 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of UPP1 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1305566 6480464 Oxazolone results in increased expression of UPP1 mRNA CTD PMID:21893156 4-hydroxyphenyl retinamide increases expression ISO RGD:1313670 6480464 Fenretinide results in increased expression of UPP1 mRNA CTD PMID:28973697 5-benzyl-1-(2-hydroxyethoxymethyl)uracil multiple interactions ISO RGD:1313670 6480464 5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine] CTD PMID:16397116 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of UPP1 mRNA, Fluorouracil results in increased expression of UPP1 protein CTD PMID:15109396 more ... 5-fluorouracil affects response to substance ISO RGD:1313670 6480464 UPP1 protein affects the susceptibility to Fluorouracil CTD PMID:15772079 5-fluorouracil multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil CTD PMID:15772079 5-fluorouracil affects response to substance EXP 6480464 UPP1 affects the susceptibility to Fluorouracil CTD PMID:15067352 6-propyl-2-thiouracil decreases expression ISO RGD:1305566 6480464 Propylthiouracil results in decreased expression of UPP1 mRNA CTD PMID:24780913 adenosine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Adenosine CTD PMID:15772079 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of UPP1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of UPP1 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of UPP1 mRNA CTD PMID:23724009 , PMID:23830798 amphetamine increases expression ISO RGD:1305566 6480464 Amphetamine results in increased expression of UPP1 mRNA CTD PMID:30779732 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of UPP1 mRNA CTD PMID:24449571 arsane affects methylation EXP 6480464 Arsenic affects the methylation of UPP1 gene CTD PMID:25304211 arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of UPP1 gene CTD PMID:25304211 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of UPP1 mRNA CTD PMID:27829220 azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of UPP1 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:1313670 6480464 Benzo(a)pyrene results in increased expression of UPP1 mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of UPP1 mRNA CTD PMID:21632981 , PMID:26238291 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of UPP1 mRNA CTD PMID:15638997 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of UPP1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of UPP1 mRNA CTD PMID:20678512 bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:1305566 6480464 bisphenol A results in increased expression of UPP1 mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of UPP1 mRNA CTD PMID:20170705 , PMID:30903817 bisphenol F increases expression ISO RGD:1313670 6480464 bisphenol F results in increased expression of UPP1 mRNA CTD PMID:30951980 bleomycin A5 decreases expression EXP 6480464 bleomycetin results in decreased expression of UPP1 mRNA CTD PMID:21040473 bortezomib multiple interactions ISO RGD:1313670 6480464 Bortezomib inhibits the reaction [TNF protein results in increased activity of UPP1 protein], Bortezomib inhibits the reaction [TNF protein results in increased expression of UPP1 mRNA] CTD PMID:16397116 bortezomib decreases activity ISO RGD:1313670 6480464 Bortezomib results in decreased activity of UPP1 protein CTD PMID:16397116 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of UPP1 mRNA CTD PMID:26079696 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of UPP1 mRNA CTD PMID:21172416 calciol decreases expression ISO RGD:1313670 6480464 Cholecalciferol results in decreased expression of UPP1 mRNA CTD PMID:16508948 calyculin a increases expression ISO RGD:1313670 6480464 calyculin A results in increased expression of UPP1 mRNA CTD PMID:25270620 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of UPP1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1313670 6480464 Nanotubes, Carbon analog results in increased expression of UPP1 mRNA, Nanotubes, Carbon results in increased expression of UPP1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1313670 6480464 Nanotubes, Carbon results in decreased expression of UPP1 mRNA CTD PMID:25620056 cefaloridine increases expression ISO RGD:1305566 6480464 Cephaloridine results in increased expression of UPP1 mRNA CTD PMID:18500788 chloropicrin affects expression EXP 6480464 chloropicrin affects the expression of UPP1 mRNA CTD PMID:26352163 chloroprene decreases expression ISO RGD:1313670 6480464 Chloroprene results in decreased expression of UPP1 mRNA CTD PMID:23125180 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of UPP1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of UPP1 mRNA CTD PMID:27392435 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of UPP1 mRNA CTD PMID:19320972 more ... copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA CTD PMID:20971185 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA CTD PMID:20971185 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of UPP1 mRNA CTD PMID:19549813 crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of UPP1 mRNA CTD PMID:25757056 crotonaldehyde increases expression EXP 6480464 2-butenal results in increased expression of UPP1 mRNA CTD PMID:20471460 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of UPP1 mRNA CTD PMID:20106945 more ... cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of UPP1 mRNA CTD PMID:24921660 cytidine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Cytidine CTD PMID:15772079 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of UPP1 mRNA CTD PMID:27829220 dibutyl phthalate decreases expression ISO RGD:1313670 6480464 Dibutyl Phthalate results in decreased expression of UPP1 mRNA CTD PMID:21266533 dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [darinaparsin results in increased expression of UPP1 mRNA] CTD PMID:22535156 diquat increases expression EXP 6480464 Diquat results in increased expression of UPP1 mRNA CTD PMID:21172416 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of UPP1 mRNA CTD PMID:24383545 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA CTD PMID:27188386 doxifluridine multiple interactions ISO RGD:1313670 6480464 5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine] more ... CTD PMID:16397116 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of UPP1 mRNA CTD PMID:18510171 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of UPP1 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of UPP1 mRNA CTD PMID:26615145 ethanol increases expression EXP 6480464 Ethanol results in increased expression of UPP1 mRNA CTD PMID:28986285 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of UPP1 mRNA CTD PMID:27664576 guanosine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Guanosine CTD PMID:15772079 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of UPP1 mRNA CTD PMID:20044591 hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of UPP1 mRNA CTD PMID:31256213 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of UPP1 mRNA CTD PMID:16984733 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA CTD PMID:28628672 manganese(II) chloride increases expression ISO RGD:1305566 6480464 manganese chloride results in increased expression of UPP1 mRNA CTD PMID:28801915 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of UPP1 mRNA CTD PMID:20044591 menadione decreases expression ISO RGD:1313670 6480464 Vitamin K 3 results in decreased expression of UPP1 mRNA CTD PMID:25270620 mercury dichloride increases expression ISO RGD:1305566 6480464 Mercuric Chloride results in increased expression of UPP1 mRNA CTD PMID:16507785 methamphetamine increases expression ISO RGD:1305566 6480464 Methamphetamine results in increased expression of UPP1 mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO RGD:1305566 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA CTD PMID:19564919 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of UPP1 mRNA CTD PMID:17379860 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of UPP1 mRNA CTD PMID:28001369 Monobutylphthalate affects expression ISO RGD:1313670 6480464 monobutyl phthalate affects the expression of UPP1 mRNA CTD PMID:19162170 N-methyl-4-phenylpyridinium increases expression ISO RGD:1305566 6480464 1-Methyl-4-phenylpyridinium results in increased expression of UPP1 mRNA CTD PMID:28801915 N-methyl-N-nitrosourea increases expression ISO RGD:1305566 6480464 Methylnitrosourea results in increased expression of UPP1 mRNA CTD PMID:17412507 N-methyl-N-nitrosourea decreases expression ISO RGD:1313670 6480464 Methylnitrosourea results in decreased expression of UPP1 mRNA CTD PMID:25270620 nickel atom increases expression EXP 6480464 Nickel results in increased expression of UPP1 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of UPP1 mRNA CTD PMID:18651567 nicotine increases expression EXP 6480464 Nicotine results in increased expression of UPP1 mRNA CTD PMID:23825647 obeticholic acid increases expression EXP 6480464 obeticholic acid results in increased expression of UPP1 mRNA CTD PMID:27939613 oxaliplatin multiple interactions ISO RGD:1305566 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA CTD PMID:25729387 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of UPP1 mRNA CTD PMID:29067470 pentobarbital affects response to substance ISO RGD:1313670 6480464 UPP1 protein affects the susceptibility to Pentobarbital CTD PMID:15772079 pentobarbital multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital CTD PMID:15772079 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of UPP1 mRNA CTD PMID:19084549 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of UPP1 mRNA CTD PMID:19159669 pirinixic acid decreases expression ISO RGD:1313670 6480464 pirinixic acid results in decreased expression of UPP1 mRNA CTD PMID:17426115 pirinixic acid increases expression ISO RGD:1313670 6480464 pirinixic acid results in increased expression of UPP1 mRNA CTD PMID:18301758 , PMID:20813756 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA CTD PMID:20660070 pyrimidine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of pyrimidine CTD PMID:15772079 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of UPP1 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:1305566 6480464 resveratrol results in increased expression of UPP1 mRNA CTD PMID:25905778 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:1305566 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA CTD PMID:19564919 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of UPP1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1313670 6480464 Silicon Dioxide results in increased expression of UPP1 mRNA CTD PMID:23221170 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of UPP1 mRNA CTD PMID:12727804 succimer multiple interactions ISO RGD:1313670 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA CTD PMID:21641980 sulindac sulfide increases expression EXP 6480464 sulindac sulfide results in increased expression of UPP1 mRNA CTD PMID:16184548 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of UPP1 mRNA CTD PMID:15336504 thalidomide decreases expression ISO RGD:1313670 6480464 Thalidomide results in decreased expression of UPP1 mRNA CTD PMID:26217789 thimerosal increases expression EXP 6480464 Thimerosal results in increased expression of UPP1 mRNA CTD PMID:16870260 topotecan multiple interactions ISO RGD:1305566 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:1305566 6480464 Topotecan results in increased expression of UPP1 mRNA CTD PMID:25729387 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of UPP1 mRNA CTD PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1305566 6480464 trimellitic anhydride results in increased expression of UPP1 mRNA CTD PMID:21893156 tris(2-butoxyethyl) phosphate increases expression EXP 6480464 tris(2-butoxyethyl) phosphate results in increased expression of UPP1 mRNA CTD PMID:29024780 trovafloxacin multiple interactions ISO RGD:1313670 6480464 [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA CTD PMID:18930950 tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of UPP1 mRNA CTD PMID:29453283 urethane increases expression EXP 6480464 Urethane results in increased expression of UPP1 mRNA CTD PMID:28818685 uridine affects abundance ISO RGD:1313670 6480464 UPP1 protein affects the abundance of Uridine CTD PMID:15772079 uridine increases metabolic processing ISO RGD:1313670 6480464 UPP1 protein results in increased metabolism of Uridine CTD PMID:15772079 uridine multiple interactions ISO RGD:1313670 6480464 [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil, [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital CTD PMID:15772079 valproic acid decreases expression ISO RGD:1313670 6480464 Valproic Acid results in decreased expression of UPP1 mRNA CTD PMID:19136453 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of UPP1 mRNA CTD PMID:19101580 more ... zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of UPP1 mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
